Prevalence, Antimicrobial Resistance Profiles, and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus Among School Children in Nha Trang, Central Vietnam
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design and Setting
2.2. Study Population
2.3. Inclusion Criteria
- The student was healthy and did not have any chronic illnesses such as asthma, congenital heart disease, etc.
- The student who did not have any febrile illness within the last month.
- For primary school students, participation required informed consent from a parent or guardian. For secondary and high school students, participation required the student’s own agreement to provide a sample and take part in the study.
2.4. Data Collection
2.5. Sample Collection
2.6. Bacterial Isolation and Identification
2.7. Antibiotic Susceptibility Testing
2.8. Molecular Analysis
2.8.1. Genomic DNA Extraction
2.8.2. Genotypical Identification
2.8.3. Determination of PVL Gene
2.8.4. Determination of SCCmec Gene Types
2.8.5. Multi-Locus Sequence Typing (MLST)
2.9. Ethical Approval
2.10. Data Analysis
3. Results
3.1. Social Demographics of the Study Participants
3.2. Antibiotic Susceptibility Patterns
3.3. MecA and PVL Genes Detection
3.4. SCCmec Distribution for MRSA
3.5. MLST of S. aureus Isolates
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| AST | Antimicrobial Susceptibility Test |
| ABR | Antibiotic Resistance |
| MDR | Multidrug Resistance |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| CA-MRSA | Community-acquired Methicillin-resistant Staphylococcus aureus |
| PCR | Polymerase Chain Reaction |
| MIC | Minimum Inhibitory Concentration |
| MLST | Multi-Locus Sequence Typing |
| NIHE | National Institute of Hygiene and Epidemiology |
| KEMRI | Kenya Medical Research Institute |
| QDA | Quinupristin/Dalfopristin |
| SXT | Sulfamethoxazole-Trimethoprim |
| SBA | Sheep Blood Agar |
| MSA | Mannitol Salt Agar |
| PBP | Penicillin-binding Protein |
| MSSA | Methicillin-sensitive S. aureus |
| CLSI | Clinical and Laboratory Standards Institute |
| PVL | Panton–Valentine Leukocidin |
| DNA | Deoxyribonucleic Acid |
| SCCmec | Staphylococcus Cassette Chromosome mec |
| Cls | Confidence Intervals |
| ORs | Odd Ratios |
| ATCC | American Type Culture Collection |
| ST | Sequence Type |
| USA | United States of America |
| NUC | Nuclease gene |
| STGG | Skim Milk–Tryptone–Glucose–Glycerol |
| NU | Nagasaki University |
| PID | Pediatric Infectious Diseases |
References
- Gherardi, G. Staphylococcus aureus Infection: Pathogenesis and Antimicrobial Resistance. Int. J. Mol. Sci. 2023, 24, 8182. [Google Scholar] [CrossRef]
- Tong, S.Y.; Davis, J.S.; Eichenberger, E.; Holland, T.L.; Fowler, V.G., Jr. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 2015, 28, 603–661. [Google Scholar] [CrossRef]
- Wong, J.W.; Ip, M.; Tang, A.; Wei, V.W.; Wong, S.Y.; Riley, S.; Read, J.M.; Kwok, K.O. Prevalence and risk factors of community-associated methicillin-resistant Staphylococcus aureus carriage in Asia-Pacific region from 2000 to 2016: A systematic review and meta-analysis. Clin. Epidemiol. 2018, 10, 1489–1501. [Google Scholar] [CrossRef]
- Esposito, S.; Terranova, L.; Zampiero, A.; Ierardi, V.; Rios, W.P.; Pelucchi, C.; Principi, N. Oropharyngeal and nasal Staphylococcus aureus carriage by healthy children. BMC Infect. Dis. 2014, 14, 723. [Google Scholar] [CrossRef] [PubMed]
- Khatri, S.; Pant, N.D.; Bhandari, R.; Shrestha, K.L.; Shrestha, C.D.; Adhikari, N.; Poudel, A. Nasal Carriage Rate of Methicillin Resistant Staphylococcus aureus among Health Care Workers at a Tertiary Care Hospital in Kathmandu, Nepal. J. Nepal. Health Res. Counc. 2017, 15, 26–30. [Google Scholar] [CrossRef]
- Wertheim, H.F.; Melles, D.C.; Vos, M.C.; van Leeuwen, W.; van Belkum, A.; Verbrugh, H.A.; Nouwen, J.L. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 2005, 5, 751–762. [Google Scholar] [CrossRef]
- Blair, J.M.; Webber, M.A.; Baylay, A.J.; Ogbolu, D.O.; Piddock, L.J. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 2015, 13, 42–51. [Google Scholar] [CrossRef]
- Harkins, C.P.; Pichon, B.; Doumith, M.; Parkhill, J.; Westh, H.; Tomasz, A.; de Lencastre, H.; Bentley, S.D.; Kearns, A.M.; Holden, M.T.G. Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biol. 2017, 18, 130. [Google Scholar] [CrossRef] [PubMed]
- Peacock, S.J.; Paterson, G.K. Mechanisms of Methicillin Resistance in Staphylococcus aureus. Annu. Rev. Biochem. 2015, 84, 577–601. [Google Scholar] [CrossRef] [PubMed]
- DeLeo, F.R.; Otto, M.; Kreiswirth, B.N.; Chambers, H.F. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010, 375, 1557–1568. [Google Scholar] [CrossRef]
- An, N.V.; Nguyen, H.T.; Nguyen Le, V.; Thu Van, H.T.; Hai, N.M.; Luong, V.H.; Nguyen, V.T.H.; Pham, H.Q.; Le, H.V.; Hung, D.V.; et al. Antimicrobial Susceptibility Profile of Methicillin-Resistant Staphylococcus Aureus Isolated from Clinical Samples at Bac Ninh Provincial General Hospital, Vietnam. Infect. Drug Resist. 2024, 17, 4113–4123. [Google Scholar] [CrossRef]
- Magiorakos, A.P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012, 18, 268–281. [Google Scholar] [CrossRef] [PubMed]
- David, M.Z.; Daum, R.S. Community-associated methicillin-resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 2010, 23, 616–687. [Google Scholar] [CrossRef] [PubMed]
- Yang, S.; Wang, B.; Li, J.; Zhao, X.; Zhu, Y.; Sun, Q.; Liu, H.; Wen, X. Genetic Diversity, Antibiotic Resistance, and Virulence Gene Features of Methicillin-Resistant Staphylococcus aureus Epidemics in Guiyang, Southwest China. Infect. Drug Resist. 2022, 15, 7189–7206. [Google Scholar] [CrossRef]
- Jonas, D.; Grundmann, H.; Hartung, D.; Daschner, F.D.; Towner, K.J. Evaluation of the mecA femB duplex polymerase chain reaction for detection of methicillin-resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 1999, 18, 643–647. [Google Scholar] [CrossRef]
- Islam, S.; Nasrin, N.; Tithi, N.S.; Khatun, F.; Asaduzzaman, M.; Topa, A.F.; Kabir, M.F.; Haque, F.K.M.; Jubair, M.; Rahman, M.; et al. Antimicrobial Susceptibility and Genomic Profiles of Multidrug-Resistant Staphylococcus aureus from Nasopharynx of Asymptomatic Children in Dhaka, Bangladesh. Life 2024, 14, 971. [Google Scholar] [CrossRef]
- Humphries, R.M.; Ambler, J.; Mitchell, S.L.; Castanheira, M.; Dingle, T.; Hindler, J.A.; Koeth, L.; Sei, K. CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests. J. Clin. Microbiol. 2018, 56, e01934-17. [Google Scholar] [CrossRef]
- Brakstad, O.G.; Aasbakk, K.; Maeland, J.A. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol. 1992, 30, 1654–1660. [Google Scholar] [CrossRef]
- Goudarzi, M.; Goudarzi, H.; AM, S.F.; Udo, E.E.; Fazeli, M.; Asadzadeh, M.; Seyedjavadi, S.S. Molecular Characterization of Methicillin Resistant Staphylococcus aureus Strains Isolated from Intensive Care Units in Iran: ST22-SCCmec IV/t790 Emerges as the Major Clone. PLoS ONE 2016, 11, e0155529. [Google Scholar] [CrossRef]
- McClure, J.A.; Conly, J.M.; Lau, V.; Elsayed, S.; Louie, T.; Hutchins, W.; Zhang, K. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci. J. Clin. Microbiol. 2006, 44, 1141–1144. [Google Scholar] [CrossRef] [PubMed]
- Zhang, K.; McClure, J.A.; Conly, J.M. Enhanced multiplex PCR assay for typing of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. Mol. Cell Probes 2012, 26, 218–221. [Google Scholar] [CrossRef]
- Saunders, N.A.; Holmes, A. Multilocus sequence typing (MLST) of Staphylococcus aureus. Methods Mol. Biol. 2014, 1085, 113–130. [Google Scholar] [CrossRef] [PubMed]
- Funaki, T.; Yasuhara, T.; Kugawa, S.; Yamazaki, Y.; Sugano, E.; Nagakura, Y.; Yoshida, K.; Fukuchi, K. SCCmec typing of PVL-positive community-acquired Staphylococcus aureus (CA-MRSA) at a Japanese hospital. Heliyon 2019, 5, e01415. [Google Scholar] [CrossRef] [PubMed]
- Lakhundi, S.; Zhang, K. Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology. Clin. Microbiol. Rev. 2018, 31, e00020-18. [Google Scholar] [CrossRef] [PubMed]
- Baye Gelaw, A.A. Nasopharyngeal Carriage Rate and Antimicrobial Susceptibility Pattern of Potential Pathogenic Bacteria among Paediatrics Outpatients at Gondar University Teaching Hospital, Ethiopia. J. Infect. Dis. Ther. 2013, 1, 109. [Google Scholar] [CrossRef]
- Kikuta, H.; Shibata, M.; Nakata, S.; Yamanaka, T.; Sakata, H.; Akizawa, K.; Kobayashi, K. Predominant Dissemination of PVL-Negative CC89 MRSA with SCCmec Type II in Children with Impetigo in Japan. Int. J. Pediatr. 2011, 2011, 143872. [Google Scholar] [CrossRef]
- Du, J.; Chen, C.; Ding, B.; Tu, J.; Qin, Z.; Parsons, C.; Salgado, C.; Cai, Q.; Song, Y.; Bao, Q.; et al. Molecular characterization and antimicrobial susceptibility of nasal Staphylococcus aureus isolates from a Chinese medical college campus. PLoS ONE 2011, 6, e27328. [Google Scholar] [CrossRef]



| Variable | Positive (N = 222 1) | Negative (N = 988 1) | Univariable Regression | ||
|---|---|---|---|---|---|
| OR | 95% CI | p-Value | |||
| Sex | |||||
| Male | 105 (17.9) | 481 (82.1) | Ref | Ref | |
| Female | 117 (18.8) | 507 (81.3) | 1.06 | 0.79–1.42 | 0.709 |
| Age group (years) | |||||
| 6–10 | 128 (26.3) | 359 (73.7) | Ref | Ref | |
| 11–14 | 58 (14.4) | 345 (85.6) | 0.47 | 0.33–0.66 | <0.001 |
| 15–18 | 36 (11.3) | 284 (88.8) | 0.36 | 0.24–0.53 | <0.001 |
| Antibiotic use in the last month | |||||
| Yes | 12 (18.2) | 54 (81.8) | Ref | Ref | |
| No | 194 (18.0) | 886 (82.0) | 0.99 | 0.53–1.96 | 0.964 |
| Took medicine, but do not know | 16 (25.0) | 48 (75.0) | 1.5 | 0.65–3.55 | 0.346 |
| Education level | |||||
| Primary school | 132 (26.0) | 376 (74.0) | Ref | Ref | |
| Secondary school | 56 (13.9) | 346 (86.1) | 0.46 | 0.32–0.65 | <0.001 |
| High school | 34 (11.3) | 266 (88.7) | 0.36 | 0.24–0.54 | <0.001 |
| School type | |||||
| Public | 220 (18.7) | 958 (81.3) | Ref | Ref | |
| Private | 2 (6.3) | 30 (93.8) | 0.29 | 0.05–0.97 | 0.092 |
| Class population | |||||
| Mean (Min–Max) | 40.5 (32.0–52.0) | 40.8 (24.0–69.0) | 1.06 | 0.91–1.22 | 0.479 |
| No of household members living together | |||||
| 2 | 5 (13.5) | 32 (86.5) | Ref | Ref | |
| 3 | 31 (14.5) | 183 (85.5) | 1.08 | 0.42–3.36 | 0.876 |
| 4 | 139 (20.6) | 535 (79.4) | 1.66 | 0.69–4.93 | 0.3 |
| 5 | 27 (14.9) | 154 (85.1) | 1.12 | 0.43–3.50 | 0.826 |
| 6 | 15 (18.8) | 65 (81.3) | 1.48 | 0.52–4.86 | 0.486 |
| >7 | 5 (20.8) | 19 (79.2) | 1.68 | 0.42–6.81 | 0.454 |
| Variable | MRSA (N = 91 1) | MSSA (N = 131 1) | Univariable Regression | ||
|---|---|---|---|---|---|
| OR | 95% CI | p-Value | |||
| Sex | |||||
| Male | 52 (49.5) | 53 (50.5) | Ref | Ref | |
| Female | 39 (33.3) | 78 (66.7) | 0.51 | 0.29–0.87 | 0.015 |
| Age group (years) | |||||
| 6–10 | 62 (48.4) | 66 (51.6) | Ref | Ref | |
| 11–14 | 19 (32.8) | 39 (67.2) | 0.52 | 0.27–0.98 | 0.047 |
| 15–18 | 10 (27.8) | 26 (72.2) | 0.41 | 0.18–0.89 | 0.030 |
| Antibiotic use in the last month | |||||
| Yes | 9 (75.0) | 3 (25.0) | Ref | Ref | |
| No | 75 (38.7) | 119 (61.3) | 0.21 | 0.05–0.73 | 0.022 |
| Took medicine, but I do not know | 7 (43.8) | 9 (56.3) | 0.26 | 0.04–1.25 | 0.106 |
| School level | |||||
| Primary school | 63 (47.7) | 69 (52.3) | Ref | Ref | |
| Secondary school | 18 (32.1) | 38 (67.9) | 0.52 | 0.26–0.99 | 0.050 |
| High school | 10 (29.4) | 24 (70.6) | 0.46 | 0.19–1.00 | 0.059 |
| School type | |||||
| Public | 91 (41.4) | 129 (58.6) | Ref | Ref | |
| Private | 0 (0.0) | 2 (100.0) | 0 | 0 | 0.988 |
| Class population | |||||
| Mean (Min–Max) | 40.7 (32.0–52.0) | 40.4 (38.0–42.0) | 1.02 | 0.95–1.09 | 0.673 |
| No of household members living together | |||||
| 2 | 2 (40.0) | 32 (86.5) | Ref | Ref | |
| 3 | 14 (45.2) | 17 (54.8) | 1.24 | 0.18–10.4 | 0.830 |
| 4 | 53 (38.1) | 86 (61.9) | 0.92 | 0.15–7.19 | 0.933 |
| 5 | 14 (51.9) | 13 (48.1) | 1.62 | 0.23–13.8 | 0.628 |
| 6 | 4 (26.7) | 11 (73.3) | 0.55 | 0.06–5.30 | 0.576 |
| >7 | 4 (80.0) | 1 (20.0) | 6.55 | 0.43–178 | 0.214 |
| Antibiotic | S. aureus N = 220 | MRSA N = 90 | MSSA N = 130 | ||||
|---|---|---|---|---|---|---|---|
| R, N (%) | S, N (%) | R, N (%) | S, N (%) | R, N (%) | S, N (%) | p-Value | |
| SXT | 220 (100.0) | 0 (0.0) | 90 (100.0) | 0 (0.0) | 130 (100.0) | 0 (0.0) | N/A |
| Erythromycin | 143 (65.0) | 77 (35.0) | 62 (68.9) | 28 (31.1) | 81 (62.3) | 49 (37.7) | 0.3 |
| Clindamycin | 94 (42.7) | 126 (57.3) | 36 (40.0) | 54 (60.0) | 54 (44.6) | 72 (55.4) | 0.5 |
| Gentamicin | 84 (38.2) | 136 (61.8) | 21 (23.3) | 69 (76.7) | 63 (48.5) | 67 (51.5) | 0.001 |
| Tetracycline | 39 (17.7) | 181 (82.3) | 12 (13.3) | 78 (86.7) | 27 (20.8) | 103 (79.2) | 0.2 |
| Moxifloxacin | 38 (17.3) | 182 (82.7) | 15 (16.7) | 75 (83.3) | 23 (17.7) | 107 (82.3) | 0.8 |
| Ciprofloxacin | 37 (16.8) | 183 (83.2) | 15 (16.7) | 75 (83.3) | 22 (16.9) | 108 (83.3) | 0.9 |
| Levofloxacin | 37 (16.8) | 183 (83.2) | 15 (16.7) | 75 (83.3) | 22 (16.9) | 108 (83.1) | 0.9 |
| Ampicillin | 18 (8.2) | 101 (45.9) | 7 (7.8) | 21 (23.3) | 11 (8.5) | 80 (61.5) | 0.001 |
| Daptomycin | 3 (1.4) | 217 (98.6) | 1 (1.1) | 89 (98.9) | 2 (1.5) | 128 (98.5) | 0.9 |
| Imipenem | 0 (0.0) | 219 (99.5) | 1 (1.1) | 89 (98.9) | 0 (0.0) | 129 (99.2) | 0.9 |
| Rifampicin | 0 (0.0) | 0 (0.0) | 0 (0.0) | 90 (100.0) | 0 (0.0) | 0 (0.0) | 0.084 |
| QDA | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | N/A |
| Linezolid | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | N/A |
| Vancomycin | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | N/A |
| Tigecycline | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | N/A |
| Nitrofurantoin | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | N/A |
| No of Antibiotics | Multi-Drug-Resistant Pattern | No of Resistance Strains (n = 90) | ||
|---|---|---|---|---|
| No | % | ST Type | ||
| 3 | ERY, CLI, SXT | 16 | (14.4) | 45,278, 546, 617, 1774 |
| GEN, TCY, SXT | 3 | (2.7) | 7, 6954 | |
| CIP, LVX, SXT | 1 | (0.9) | 188 | |
| ERY, SXT, AMP | 1 | (0.9) | 45 | |
| ERY, TCY, SXT | 1 | (0.9) | 1906 | |
| 4 | GEN, ERY, CLI, SXT | 23 | (20.7) | 1, 14, 45, 278, 296, 320 |
| ERY, CLI, TCY, SXT | 8 | (7.2) | 45, 199, 610, 617, 1232 | |
| GEN, ERY, TCY, SXT | 8 | (7.2) | 14, 15, 278, 320, 1659 | |
| ERY, CLI, SXT, AMP | 1 | (0.9) | 45 | |
| GEN, CLI, LVX, SXT | 1 | (0.9) | 2372 | |
| 5 | GEN, ERY, CLI, TCY, SXT | 6 | (5.4) | 88, 264, 319, 411, 2261 |
| GEN, ERY, CLI, SXT, AMP | 3 | (2.7) | 320, 411 | |
| ERY, CLI, TCY, SXT, AMP | 2 | (1.8) | 400, 567 | |
| GEN, CIP, LVX, MFX, SXT | 1 | (0.9) | 8141 | |
| GEN, ERY, CLI, SXT, DAP | 1 | (0.9) | 45 | |
| 6 | GEN, CIP, LVX, ERY, CLI, SXT | 1 | (0.9) | 2201 |
| GEN, CIP, LVX, ERY, TCY, SXT | 1 | (0.9) | 320 | |
| GEN, ERY, CLI, TCY, SXT, AMP | 1 | (0.9) | 188 | |
| 7 | GEN, CIP, LVX, MFX, ERY, CLI, SXT | 18 | (16.2) | 148, 188, 296, 411, 617 |
| CIP, LVX, MFX, ERY, CLI, TCY, SXT | 1 | (0.9) | 2655 | |
| GEN, CIP, LVX, ERY, CLI, SXT, AMP | 1 | (0.9) | 1054 | |
| GEN, CIP, LVX, ERY, CLI, TCY, SXT | 1 | (0.9) | 546 | |
| 8 | GEN, CIP, LVX, MFX, ERY, CLI, SXT, AMP | 7 | (6.3) | 188, 296, 567, 617 |
| GEN, CIP, LVX, MFX, ERY, CLI, TCY, SXT | 2 | (1.8) | 188, 2139 | |
| 9 | GEN, CIP, LVX, MFX, ERY, CLI, TCY, SXT, AMP | 2 | (1.8) | 6775 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Omae, S.A.; Monir, S.M.; Nguyen, H.-A.T.; Huynh, K.-M.; Ariyoshi, N.; Le, L.T.; Le, D.T.; Nguyen, T.B.; Le, H.H.; Nguyen, L.D.; et al. Prevalence, Antimicrobial Resistance Profiles, and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus Among School Children in Nha Trang, Central Vietnam. Pathogens 2026, 15, 238. https://doi.org/10.3390/pathogens15020238
Omae SA, Monir SM, Nguyen H-AT, Huynh K-M, Ariyoshi N, Le LT, Le DT, Nguyen TB, Le HH, Nguyen LD, et al. Prevalence, Antimicrobial Resistance Profiles, and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus Among School Children in Nha Trang, Central Vietnam. Pathogens. 2026; 15(2):238. https://doi.org/10.3390/pathogens15020238
Chicago/Turabian StyleOmae, Stephen Anyona, Shah Mohammad Monir, Hien-Anh Thi Nguyen, Kim-Mai Huynh, Natsuki Ariyoshi, Lien Thuy Le, Dat Thanh Le, Trieu Bao Nguyen, Hoang Huy Le, Luong Dinh Nguyen, and et al. 2026. "Prevalence, Antimicrobial Resistance Profiles, and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus Among School Children in Nha Trang, Central Vietnam" Pathogens 15, no. 2: 238. https://doi.org/10.3390/pathogens15020238
APA StyleOmae, S. A., Monir, S. M., Nguyen, H.-A. T., Huynh, K.-M., Ariyoshi, N., Le, L. T., Le, D. T., Nguyen, T. B., Le, H. H., Nguyen, L. D., Tsuruoka, M., Otomaru, H., Koehne, E., Toizumi, M., Dang, D.-A., Do, H. T., & Yoshida, L.-M. (2026). Prevalence, Antimicrobial Resistance Profiles, and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus Among School Children in Nha Trang, Central Vietnam. Pathogens, 15(2), 238. https://doi.org/10.3390/pathogens15020238

